LifeScience Biologics

Revvity and Element Biosciences Collaborate to Enhance NGS Research Workflow

Next generation sequencing workflow with research use only components from both companies is designed to provide flexibility, time and cost savings on sa...

 October 17, 2023 | News

Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions

Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...

 October 16, 2023 | News

B. Braun Announces Comprehensive Resources to Address Health Inequities in Vascular Access and Care

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced  at the Association for Vascular Access (AVA) Scie...

 October 16, 2023 | News

Nona Biosciences and INGENIA Therapeutics Join Forces for Immunology Breakthroughs

By harnessing the immense expertise and resources of both companies, the collaboration aims to accelerate the development of innovative therapeutics for im...

 October 16, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

 First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

 October 13, 2023 | News

CARsgen's CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...

 October 13, 2023 | News

MediLink and BioNTech Partner for Advanced Anti-Cancer Drug

Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...

 October 13, 2023 | News

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...

 October 12, 2023 | News

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...

 October 11, 2023 | News

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Headquartered in Beijing, China, Sino Biological is the world’s leading provider of mammalian cell-based recombinant proteins, antibodies, and relate...

 October 10, 2023 | News

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb to Acquire Mirati for $58.00 Per Share, Representing $4.8 Billion Equity Value and Up to $5.8 Billion Including the Contingent Value R...

 October 10, 2023 | News

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

The technologies licensed to Telethon are based on Takara Bio’s proprietary RetroNectin® method, which includes a technology enabling highly effi...

 October 05, 2023 | News

New hot start isothermal mixes boost sensitivity, specificity, and speed of DNA target detection

Isothermal mixes are important in a range of isothermal amplification applications, including whole genome amplification, point-of-care assay development a...

 September 29, 2023 | News

SGC and HitGen Partner for DNA-Encoded Drug Discovery

HitGen will utilize its DNA-encoded library (DEL) technology platform, specifically OpenDEL™, to screen under-represented targets chosen by SGC. &nbs...

 September 29, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close